XML 35 R23.htm IDEA: XBRL DOCUMENT v3.25.3
EARNINGS PER SHARE
9 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
EARNINGS PER SHARE
NOTE 15—EARNINGS PER SHARE

The following table shows the amounts used in computing our basic and diluted earnings per share (in thousands, except per share amounts):

 For the Three Months Ended September 30,For the Nine Months Ended September 30,
 2025202420252024
Numerator for basic and diluted earnings per share:  
Net income$68,708 $20,996 $188,526 $29,624 
Net income attributable to noncontrolling interests2,661 1,753 7,347 5,306 
Net income attributable to common stockholders$66,047 $19,243 $181,179 $24,318 
Denominator:  
Denominator for basic earnings per share—weighted average shares456,032 414,599 449,572 408,691 
Effect of dilutive securities:  
Restricted stock awards573 476 553 340 
OP unitholder interests3,376 3,415 3,386 3,427 
Exchangeable Notes2,912 964 2,556 321 
Equity forward sales agreements522 19 325 
Denominator for diluted earnings per share—adjusted weighted average shares463,415 419,474 456,392 412,785 
Basic earnings per share:  
Net income$0.15 $0.05 $0.42 $0.07 
Net income attributable to common stockholders0.14 0.05 0.40 0.06 
Diluted earnings per share:
    
Net income$0.15 $0.05 $0.41 $0.07 
Net income attributable to common stockholders0.14 0.05 0.40 0.06 

The dilutive effect of our Exchangeable Notes is calculated using the if-converted method in accordance with ASU 2020-06. We are required, pursuant to the indenture governing the Exchangeable Notes, to settle the aggregate principal amount of the Exchangeable Notes in cash and may elect to settle any remaining exchange obligation (i.e., the stock price in excess of the exchange obligation) in cash, shares of our common stock or a combination thereof. Under the if-converted method, we include the number of shares required to satisfy the exchange obligation, assuming all the Exchangeable Notes are exchanged. The average closing price of our common stock for the three and nine months ended September 30, 2025 is used as the basis for determining the dilutive effect on earnings per share.

Our unsettled equity forward sales agreements do not impact basic earnings per share. We apply the treasury stock method to our unsettled equity forward sales agreements to determine their dilutive effect, if any. See “Note 14 – Stockholders' Equity.”